NCT05775874 2023-03-20A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUCAbbisko Therapeutics Co, LtdPhase 2 Unknown80 enrolled
NCT05086666 2021-10-21A Phase 1b/2 Clinical Study to Evaluate the Safety and Tolerability and Efficacy of AZD4547Abbisko Therapeutics Co, LtdPhase 1/2 Unknown108 enrolled
NCT00979134 2019-03-15Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced TumoursAstraZenecaPhase 1 Terminated95 enrolled 19 charts
NCT01213160 2016-06-29Study to Assess Safety and Tolerability of AZD4547 in Japanese PatientAstraZenecaPhase 1 Completed40 enrolled